These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21083022)

  • 1. Noninvasive approach for the management of hemolytic disease of the fetus.
    Illanes S; Soothill P
    Expert Rev Hematol; 2009 Oct; 2(5):577-82. PubMed ID: 21083022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of red cell alloimmunisation in pregnancy: the non-invasive monitoring of the disease.
    Illanes S; Soothill P
    Prenat Diagn; 2010 Jul; 30(7):668-73. PubMed ID: 20572110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic disease of the fetus and newborn in the molecular era.
    Fasano RM
    Semin Fetal Neonatal Med; 2016 Feb; 21(1):28-34. PubMed ID: 26589360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.
    Delaney M; Matthews DC
    Hematology Am Soc Hematol Educ Program; 2015; 2015():146-51. PubMed ID: 26637714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of rhesus alloimmunization in pregnancy.
    Moise KJ
    Obstet Gynecol; 2008 Jul; 112(1):164-76. PubMed ID: 18591322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on HDFN: new information on long-standing controversies.
    Eder AF
    Immunohematology; 2006; 22(4):188-95. PubMed ID: 17430078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of anti-Jka alloimmunization.
    Franco A; Rossi K; Krugh D; O'Shaughnessy R
    J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
    Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
    Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of fetal anemia with Doppler ultrasound in the pregnancy complicated by maternal blood group immunization.
    Mari G; Adrignolo A; Abuhamad AZ; Pirhonen J; Jones DC; Ludomirsky A; Copel JA
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):400-5. PubMed ID: 7552802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
    Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doppler ultrasound velocimetry for timing the second intrauterine transfusion in fetuses with anemia from red cell alloimmunization.
    Detti L; Oz U; Guney I; Ferguson JE; Bahado-Singh RO; Mari G;
    Am J Obstet Gynecol; 2001 Nov; 185(5):1048-51. PubMed ID: 11717631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
    Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
    Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prenatal genotyping of the RhD locus by polymerase chain reaction in fetus at risk of hemolytic disease].
    Misković B; Stipoljev F; Hadzisejdić I; Grahovac B
    Lijec Vjesn; 2008; 130(1-2):4-6. PubMed ID: 18589635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive fetal RhD genotyping.
    Clausen FB; Damkjær MB; Dziegiel MH
    Transfus Apher Sci; 2014 Apr; 50(2):154-62. PubMed ID: 24642067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn.
    Daniels G; Finning K; Martin P; Soothill P
    Vox Sang; 2004 Nov; 87(4):225-32. PubMed ID: 15585017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal anaemia as a cause of fetal injury: diagnosis and management.
    Chan LW; Lau TK; Chung TK
    Curr Opin Obstet Gynecol; 2006 Apr; 18(2):100-5. PubMed ID: 16601468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of maternal blood in the management of severe hemolytic disease of the fetus and newborn due to anti-Kp(b).
    Bleile MJ; Rijhsinghani A; Dwyre DM; Raife TJ
    Transfus Apher Sci; 2010 Dec; 43(3):281-283. PubMed ID: 20951648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.